Irbesartan Tablets

The main ingredient of this product is irbesartan.

This product is white to off-white tablets.

Oral: The recommended starting dose is 0.15g, once a day. It can be increased to 0.3g, once a day, depending on the condition. It can be used alone or in combination with other antihypertensive drugs. For severe hypertension and when the blood pressure is still not reduced satisfactorily after the increase in drug dosage, a small dose of diuretics (such as thiazides) or other antihypertensive drugs can be added.

Common adverse reactions include headache, dizziness, palpitations, and occasional cough, which are generally mild and transient, and most patients can tolerate the medication. Urticaria and angioneurotic edema are rare. Literature reports that the incidence of adverse reactions of this product is greater than 1% including indigestion, heartburn, diarrhea, skeletal muscle pain, fatigue, and upper respiratory tract infection, but there is no significant difference compared with the blank control group. The incidence of adverse reactions greater than 1% but lower than the control group includes abdominal pain, anxiety, nervousness, chest pain, pharyngitis, nausea and vomiting, rash, tachycardia, etc. The incidence of hypotension and orthostatic hypotension is about 0.4%.

It is contraindicated for those who are allergic to this product.

Precautions for children: There is no data on the safety of the drug for patients under 18 years old. Precautions for pregnancy and lactation: It is contraindicated for pregnant and lactating women. Precautions for the elderly: It is not clear yet.

1. When this product is used in combination with diuretics, attention should be paid to insufficient blood volume or hypotension caused by low sodium. When used in combination with potassium-sparing diuretics (such as triamterene, etc.), elevated blood potassium should be avoided. 2. There is no obvious interaction between this product and warfarin. 3. When used in combination with digitalis drugs such as digoxin, blockers such as atenolol, calcium antagonists such as nifedipine, etc., it does not affect the pharmacokinetics of each other.

Keep sealed.

75 mg x 12 tablets

36 months

YANGTZE River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co., Ltd.

• Founded in:

  2011-12-06

• Address:

  No. 9, Yunhe West Road, Xuejia Town, Xinbei District, Changzhou

• Tax NO.:

  913204115866741675

• Registered Funds:

  250 million yuan

• Website:

  Log in to view

• Email:

  Log in to view